Industry News
Viralytics and MSD collaborate on combination cancer trial
A new clinical trial will evaluate the combination of Viralytics' investigational cancer immunotherapy, CAVATAK, with MSD's KEYTRUDA, an anti-PD-1 (programmed death receptor-1) therapy. [ + ]
Australia gains access to Earth observation program
A cooperation arrangement signed in Brussels will provide Australia with access to what is said to be the most comprehensive Earth observation program in world history. [ + ]
Academy issues $190,000 in funding
The Australian Academy of Science has announced $190,000 to help the survival of some of Australia's endangered species, help prevent hospital readmissions in central Australia, model climate change adaptation and support international travel and scientific conferences. [ + ]
Merck and Selvita collaborate on drug discovery
Merck's healthcare business has entered into a three-year collaboration to validate new therapeutic concepts in the field of oncology with drug discovery company Selvita, headquartered in Poland. [ + ]
How to breed a better working dog
University of Sydney researchers have identified and mapped the genetic traits that will improve the accuracy of breeding high-performing working dogs for Australian farmers. [ + ]
Unusual phase of matter uncovered
Physicists have discovered a phase that is characterised by an unusual ordering of electrons. It is said that the phase could hold the solution to a longstanding mystery in condensed matter physics. [ + ]
Protein for progressing autoimmune diseases identified
Researchers have identified the key protein involved in driving the progression of multiple sclerosis (MS) and other autoimmune diseases through the body's 'super-inflammatory' immune response. [ + ]
899 new research projects funded
Senator Simon Birmingham has confirmed funding for 889 new research projects as part of the Australian Research Council's (ARC) Major Grants announcement. [ + ]
Chemists create a star-shaped molecule
Chemists have created a star-shape molecule, previously thought to be too unstable to be made, in work which could lead to more efficient ways to make medicinal agents.
[ + ]Potential new treatment for tuberculosis
Scientists have discovered a potential new treatment for tuberculosis — a disease whose resistance to current medical therapies has enabled it to infect 30% of the globe's population.
[ + ]So guppies can count
Researchers have discovered that the humble guppy may be smarter than other fish, with strongly lateralised brains that give them the ability to count. [ + ]
Cancer vaccine trial underway
Regeneus has announced that the first patient has been enrolled and treated in a clinical trial of the company's autologous tumour vaccine, RGSH4K. [ + ]
Methane-metabolising microorganisms discovered
Scientists from The University of Queensland have discovered two new microorganisms which are said to play an unknown role in greenhouse gas emissions and consumption. [ + ]
Meet Australia's new Chief Scientist
Prime Minister Malcolm Turnbull has announced that Dr Alan Finkel AO will be Australia's next Chief Scientist. [ + ]
Licence agreement for TGR immunoassay technology
TGR BioSciences has announced a European licence agreement with Prime Diagnostics — a developer of high-quality diagnostics, technologies and services for the agricultural sector. [ + ]
